2.60Open2.85Pre Close71 Volume611 Open Interest110.00Strike Price19.06KTurnover20.57%IV1.60%PremiumJul 19, 2024Expiry Date0.96Intrinsic Value100Multiplier19DDays to Expiry1.74Extrinsic Value100Contract SizeAmericanOptions Type-0.5475Delta0.0790Gamma44.96Leverage Ratio-0.0463Theta-0.0263Rho-24.62Eff Leverage0.0985Vega
JM Smucker Stock Discussion
Chewy ( $Chewy(CHWY.US)$ ): Cramer praised Chewy's recent rebound and earnings growth, driven by positive trends in pet adoption.
Elanco ( $Elanco Animal Health(ELAN.US)$ ): A spin-off from Eli Lilly, Elanco has a promising pipeline, including treatments for canine parvovirus and diabetes in cats.
J.M. Smucker ( $JM Smucker(SJM.US)$ ): ...
My name is Kevin Travers. I am home sick today, but h...
$WIMI Evaluate Research reiterated a "buy" rating with $7 latest price target for WIMI Hologram Cloud(NASDAQ: WIMI)
$PACB Barclays Trims Pacific Biosciences of California (NASDAQ:PACB) Target Price to $3.00
$NFLX Netflix, Inc. (NASDAQ:NFLX) Receives $590.15 Consensus Target Price from Brokerages
$SNOW Brokerages Set Snowflake Inc. (NYSE:SNOW) Target Price at $202.50
$RCI Barclays Trims Rogers Communications (NYSE:RCI) Target Price to $46.00
$CERE Cerevel Thera...
Gapping up
$CVS Health(CVS.US)$ has forecasted revenue for 2024 to be at least $366 billion, which exceeds the current Street estimate of $345.5 billion. The company anticipates adjusted earnings per share of at least $8.50, in line with the consensus, with the cash flow from operations projected to be at least $12.5 billion. Updates were shared ahead of the company's 2023 Investor Day. CVS shares rose 2.2% on the ne...
No comment yet